Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90033


Purpose:

To validate the outcome measures and the tolerability of Kuvan treatment in the improvement of behavioral symptoms in 10 selected adults with Phenylketonuria (PKU) with or without mental retardation.


Criteria:

Inclusion Criteria: - Biochemical confirmation of PKU, - Measurable maladaptive behavior at baseline, - Signed informed consent, - Not pregnant or lactating, - Females on birth control if applicable, - Willing to comply. Exclusion Criteria: - Subjects or care provider unreliable, use of investigational products within 30 days prior to enrollment, - Pregnant or lactating, - Concurrent disease or condition that would interfere with study participation or safety, ie multiple psychotropic meds, any condition the PI renders the subject at high risk, on drugs that inhibit folate synthesis, - Concurrent use of levodopa.


NCT ID:

NCT00728676


Primary Contact:

Principal Investigator
Shoji Yano, MD, Ph.D.
University of Southern California


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90033
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.